Latest Financial Reporting News

Cazaly Resources has exercised its option to earn up to 80% of the Goongarrie Gold Project, initiating planned drilling at key prospects while maintaining a solid cash position of $3.3 million at quarter-end.

VHM Limited has achieved a key milestone with mining licence approval for its Goschen Rare Earths and Mineral Sands Project, alongside a revised staged expansion plan that adjusts capital and operating costs while extending Major Project Status.

Li-S Energy Limited reported solid progress in its March 2025 quarter, advancing a key collaboration with Kea Aerospace to integrate lithium-sulfur batteries into high-altitude UAVs, while strengthening its board and maintaining a healthy cash position.

Alchemy Resources Limited reported a modest net cash outflow in operating activities for Q1 2025 but ended the quarter with a robust cash balance supporting over 17 quarters of funding.

Red Mountain Mining has advanced exploration across its Fry Lake, Armidale, and Kiabye projects, identifying promising gold and antimony targets and preparing for follow-up drilling and sampling programs.

Orbital Corporation Ltd reported a positive operating cash flow of $0.7 million for Q1 2025, supported by a solid order book and ongoing development of a new larger capacity engine prototype.

My Rewards International has completed its acquisition of Fly Wallet and strengthened its financial position with a $15 million put option facility, while working to lift its ASX trading suspension.

Bubs Australia has triumphed in a long-standing legal dispute, winning $26.5 million in arbitration awards against Alpha Group subsidiaries Alice Trading and Willis Trading. The company now faces the challenge of recovering the awarded sums.

Tigers Realm Coal’s planned divestment of its Russian subsidiaries has hit significant regulatory roadblocks, resulting in a reduced sale price, increased exit tax, and suspension from ASX trading.

Pact Group Holdings has announced its intention to voluntarily delist from the ASX, citing a concentrated shareholder base, low liquidity, and high regulatory costs. Shareholder approval will be sought at an extraordinary general meeting in June 2025.

Immutep Limited has dosed the first patient in its pivotal Phase III lung cancer trial and completed enrolments in multiple studies, supported by a robust cash position expected to fund operations through 2026.

Iluka Resources Limited has announced a fully franked ordinary dividend of AUD 0.04 per share for the financial year ending December 31, 2024, with key dates set for March 2025.